Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Mallinckrodt
McKinsey
Dow
Medtronic

Last Updated: June 26, 2022

Drug Price Trends for IMIPRAMINE HCL


✉ Email this page to a colleague

« Back to Dashboard

Drug Price Trends for IMIPRAMINE HCL

Average Pharmacy Cost for IMIPRAMINE HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
IMIPRAMINE HCL 50 MG TABLET 69315-0135-10 0.13296 EACH 2021-06-23
IMIPRAMINE HCL 10 MG TABLET 00781-1762-01 0.09796 EACH 2021-06-23
IMIPRAMINE HCL 10 MG TABLET 49884-0054-01 0.09796 EACH 2021-06-23
IMIPRAMINE HCL 10 MG TABLET 69315-0133-01 0.09796 EACH 2021-06-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for IMIPRAMINE HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
IMIPRAMINE HCL 10MG TAB Nationwide Pharmaceutical LLC 69584-0425-10 100 4.93 0.04930 EACH 2022-04-15 - 2026-04-30 FSS
IMIPRAMINE HCL 10MG TAB Nationwide Pharmaceutical LLC 69584-0425-90 1000 45.99 0.04599 EACH 2022-04-15 - 2026-04-30 FSS
IMIPRAMINE HCL 25MG TAB Nationwide Pharmaceutical LLC 69584-0426-10 100 5.86 0.05860 EACH 2022-04-15 - 2026-04-30 FSS
IMIPRAMINE HCL 25MG TAB Nationwide Pharmaceutical LLC 69584-0426-90 1000 54.15 0.05415 EACH 2022-04-15 - 2026-04-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Mallinckrodt
Colorcon
Express Scripts
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.